204 related articles for article (PubMed ID: 11313422)
21. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
[TBL] [Abstract][Full Text] [Related]
22. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
[TBL] [Abstract][Full Text] [Related]
23. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
24. Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice.
de Vries A; van Oostrom CT; Dortant PM; Beems RB; van Kreijl CF; Capel PJ; van Steeg H
Mol Carcinog; 1997 May; 19(1):46-53. PubMed ID: 9180928
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor receptor agonists mediate xeroderma pigmentosum A photosensitivity.
Yao Y; Harrison KA; Al-Hassani M; Murphy RC; Rezania S; Konger RL; Travers JB
J Biol Chem; 2012 Mar; 287(12):9311-21. PubMed ID: 22303003
[TBL] [Abstract][Full Text] [Related]
26. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies.
Ishikawa T; Ide F; Qin X; Zhang S; Takahashi Y; Sekiguchi M; Tanaka K; Nakatsuru Y
Mutat Res; 2001 Jun; 477(1-2):41-9. PubMed ID: 11376685
[TBL] [Abstract][Full Text] [Related]
27. Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells.
Qu M; Muller HK; Woods GM
Carcinogenesis; 1997 Jun; 18(6):1277-9. PubMed ID: 9214614
[TBL] [Abstract][Full Text] [Related]
28. Use of DNA repair-deficient XPA transgenic mice in short-term carcinogenicity testing.
van Steeg H; Klein H; Beems RB; van Kreijl CF
Toxicol Pathol; 1998; 26(6):742-9. PubMed ID: 9864090
[TBL] [Abstract][Full Text] [Related]
29. Studies of in vivo mutations in rpsL transgene in UVB-irradiated epidermis of XPA-deficient mice.
Murai H; Takeuchi S; Nakatsu Y; Ichikawa M; Yoshino M; Gondo Y; Katsuki M; Tanaka K
Mutat Res; 2000 May; 450(1-2):181-92. PubMed ID: 10838142
[TBL] [Abstract][Full Text] [Related]
30. A transgenic mouse model of skin cancer in XPA-deficient humans.
O'Neill TP
Toxicol Pathol; 1996; 24(5):642-3. PubMed ID: 8923688
[No Abstract] [Full Text] [Related]
31. Chemopreventive effect of a novel, selective TACE inhibitor on DMBA- and TPA-induced skin carcinogenesis.
Sharma M; Mohapatra J; Argade A; Deshpande SS; Shah GB; Chatterjee A; Jain MR
Immunopharmacol Immunotoxicol; 2014 Aug; 36(4):282-9. PubMed ID: 24946851
[TBL] [Abstract][Full Text] [Related]
32. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.
Marchetto MC; Muotri AR; Burns DK; Friedberg EC; Menck CF
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17759-64. PubMed ID: 15598745
[TBL] [Abstract][Full Text] [Related]
33. Indomethacin inhibits the chemical carcinogen benzo(a)pyrene but not dimethylbenz(a)anthracene from altering Langerhans cell distribution and morphology.
Andrews FJ; Halliday GM; Narkowicz CK; Muller HK
Br J Dermatol; 1991 Jan; 124(1):29-36. PubMed ID: 1899617
[TBL] [Abstract][Full Text] [Related]
34. Mutagenesis and carcinogenesis in nucleotide excision repair-deficient XPA knock out mice.
van Steeg H; Mullenders LH; Vijg J
Mutat Res; 2000 May; 450(1-2):167-80. PubMed ID: 10838141
[TBL] [Abstract][Full Text] [Related]
35. Autophagy induction on impaired spermatogenesis of xeroderma pigmentosum group A gene-deficient mice.
Nakane H; Higaki K; Koyama Y; Nanba E; Kaidoh T
Biomed Res; 2020; 41(5):237-242. PubMed ID: 33071259
[TBL] [Abstract][Full Text] [Related]
36. A role for prostaglandins in the suppression of cutaneous cellular immunity and tumour development in benzo(a)pyrene- but not dimethylbenz(a)anthracene-treated mice.
Andrews J; Halliday GM; Muller HK
Clin Exp Immunol; 1991 Jul; 85(1):9-13. PubMed ID: 1906386
[TBL] [Abstract][Full Text] [Related]
37. Decreased UV sensitivity, mismatch repair activity and abnormal cell cycle checkpoints in skin cancer cell lines derived from UVB-irradiated XPA-deficient mice.
Ichikawa M; Nakane H; Marra G; Corti C; Jiricny J; Fitch M; Ford JM; Ikejima M; Shimada T; Yoshino M; Takeuchi S; Nakatsu Y; Tanaka K
Mutat Res; 2000 May; 459(4):285-98. PubMed ID: 10844242
[TBL] [Abstract][Full Text] [Related]
38. The photocarcinogenesis of antibiotic lomefloxacin and UVA radiation is enhanced in xeroderma pigmentosum group A gene-deficient mice.
Itoh T; Miyauchi-Hashimoto H; Sugihara A; Tanaka K; Horio T
J Invest Dermatol; 2005 Sep; 125(3):554-9. PubMed ID: 16117798
[TBL] [Abstract][Full Text] [Related]
39. Induction of tolerance via skin depleted of Langerhans cells by a chemical carcinogen.
Halliday GM; Muller HK
Cell Immunol; 1986 Apr; 99(1):220-7. PubMed ID: 2944623
[TBL] [Abstract][Full Text] [Related]
40. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice.
Antonopoulos C; Cumberbatch M; Dearman RJ; Daniel RJ; Kimber I; Groves RW
J Immunol; 2001 Mar; 166(6):3672-7. PubMed ID: 11238606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
